EMA’s recommendations to prevent medicines shortages By Giuliana Miglierini Continuity of medicinal product supply is still representing a key issue for European countries. The…
The new MHRA’s framework for clinical studies By Giuliana Miglierini The repositioning of the United Kingdom as a global leader for clinical development of medicinal…
The EU Commission proposal of the new pharmaceutical legislation By Giuliana Miglierini After a five-months delay, the European Commission has announced on 26 April 2023 its proposal…
Current inspection trends and new approaches to the monitoring of post-inspection activities by Giuliana Miglierini The European Federation of Pharmaceutical Industries and Associations (EFPIA) has published its Annual Regulatory GMP/GDP…
EMA’s consultation on draft Q&As on remote certification of batches by QP by Giuliana Miglierini The last two years saw the implementation of a high degree of regulatory flexibility as…
A study on medicines shortages from the European Commission by Giuliana Miglierini The study on medicines shortages commissioned in March 2020 by the European Commission upon request…